8-K - Apogee Therapeutics, Inc. - 5.02
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001193125-26-177288
Filing Date: 2026-04-24
Accepted: 2026-04-24 16:15:18
Documents: 9
Period of Report: 2026-04-21
Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Apogee Therapeutics, Inc. (Filer) CIK : 0001974640 (see all company filings) EIN. : 934958665 | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-41740 | Film No.: 26894160 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)
1 | 8-K | apge-20260421.htm iXBRL | 8-K
2 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | apge-20260421.xsd | EX-101.SCH
12 | EXTRACTED XBRL INSTANCE DOCUMENT | apge-20260421_htm.xml | XML